2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Kenneth Ain: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas Lenalidomide - Thyroid Neoplasms | Phase 2 | Completed | Kenneth Ain | 25 | 2006-02-01 | 2020-06-12 |
| Thalidomide in Treating Patients With Thyroid Cancer thalidomide - Head and Neck Cancer | Phase 2 | Completed | Kenneth Ain | 2001-06-01 | 2017-06-06 |
Thyroid Neoplasms (2) · Adenocarcinoma, Follicular (1) · Carcinoma, Medullary (1) · Head and Neck Neoplasms (1) · Thyroid Cancer, Papillary (1)
Lenalidomide (1) · Thalidomide (1)
United States (2)